Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

The development of direct-acting antiviral (DAA) agents has reinvigorated the treatment of hepatitis C virus infection. The availability of multiple DAA agents and drug combinations has enabled the transition to interferon-free therapy that is applicable to a broad range of patients. However, these...

Descripción completa

Detalles Bibliográficos
Autores principales: Badri, Prajakta S., King, Jennifer R., Polepally, Akshanth R., McGovern, Barbara H., Dutta, Sandeep, Menon, Rajeev M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761011/
https://www.ncbi.nlm.nih.gov/pubmed/26330025
http://dx.doi.org/10.1007/s40262-015-0317-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761011/
https://www.ncbi.nlm.nih.gov/pubmed/26330025
http://dx.doi.org/10.1007/s40262-015-0317-8

Ejemplares similares